- Home
- CTNT vs GTBP Comparison
CTNT vs GTBP Comparison
Compare CTNT & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- GTBP
- Stock Information
- Founded
- CTNT 2016
- GTBP 1965
- Country
- CTNT United States
- GTBP United States
- Employees
- CTNT N/A
- GTBP N/A
- Industry
- CTNT
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- CTNT
- GTBP Health Care
- Exchange
- CTNT Nasdaq
- GTBP Nasdaq
- Market Cap
- CTNT 5.0M
- GTBP 5.5M
- IPO Year
- CTNT 2023
- GTBP N/A
- Fundamental
- Price
- CTNT $1.38
- GTBP $2.27
- Analyst Decision
- CTNT Hold
- GTBP Strong Buy
- Analyst Count
- CTNT 1
- GTBP 1
- Target Price
- CTNT N/A
- GTBP $11.00
- AVG Volume (30 Days)
- CTNT 32.7K
- GTBP 17.3K
- Earning Date
- CTNT 05-05-2025
- GTBP 05-19-2025
- Dividend Yield
- CTNT N/A
- GTBP N/A
- EPS Growth
- CTNT N/A
- GTBP N/A
- EPS
- CTNT N/A
- GTBP N/A
- Revenue
- CTNT $858,770.00
- GTBP N/A
- Revenue This Year
- CTNT N/A
- GTBP N/A
- Revenue Next Year
- CTNT $25.00
- GTBP N/A
- P/E Ratio
- CTNT N/A
- GTBP N/A
- Revenue Growth
- CTNT N/A
- GTBP N/A
- 52 Week Low
- CTNT $1.20
- GTBP $1.72
- 52 Week High
- CTNT $236.16
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- CTNT 42.50
- GTBP 47.10
- Support Level
- CTNT $1.26
- GTBP $2.30
- Resistance Level
- CTNT $1.55
- GTBP $2.40
- Average True Range (ATR)
- CTNT 0.13
- GTBP 0.15
- MACD
- CTNT -0.01
- GTBP 0.00
- Stochastic Oscillator
- CTNT 19.67
- GTBP 21.82
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a one-stop services including Warehousing, Logistics, International trading & Supply Chain Finance, Etc. It operate in single segment Logistics and warehousing services which focuses on providing freight forwarding services for clients shipping goods from the U.S. to mainland China or Hong Kong. Its services include: (i) cargo storage, (ii) freight forwarding, (iii) U.S. customs clearance, and (iv) labor services and cargo loading and unloading.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.